In AD, Aβ disrupts the glutamate–glutamine cycle, and EAAT2 deficiency causes glutamate accumulation, activating extrasynaptic NMDA receptors and accelerating neuronal damage. Here, SLC1A2 is linked to Alzheimer disease.